Design and development of thiolated graphene oxide nanosheets for brain tumor targeting

Ajinkya N. Nikam, Mahesh P. More, Abhijeet P. Pandey, Pravin O. Patil, Ashwini G. Patil, Prashant K. Deshmukh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The present investigation emphasizes on synthesis and characterization of thiol functionalized reduced graphene oxide (TrGO) as a novel platform for loading of anticancer drug methotrexate (TrGO-MTX), through amide bonding. Thiolation of graphene oxide (GO) was achieved by transesterification process. The introduction of sulfur containing chemical groups and the partial reduction of GO to TrGO were proven by analytical techniques. Thiol content was found to be 6.98 mM by Ellman’s method in a quantitative manner. Furthermore, antineoplastic action of TrGO-MTX against human glioblastoma astrocytom U-373 MG cell line was studied, wherein TrGO-MTX demonstrated significant inhibition rate as compared with pure MTX.

Original languageEnglish
JournalInternational Journal of Polymeric Materials and Polymeric Biomaterials
DOIs
Publication statusAccepted/In press - 01-01-2019
Externally publishedYes

Fingerprint

Graphite
Nanosheets
Oxides
Graphene
Tumors
Brain
Sulfhydryl Compounds
Transesterification
Amides
Sulfur
Methotrexate
Antineoplastic Agents
Cells
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Chemical Engineering(all)
  • Polymers and Plastics

Cite this

Nikam, Ajinkya N. ; More, Mahesh P. ; Pandey, Abhijeet P. ; Patil, Pravin O. ; Patil, Ashwini G. ; Deshmukh, Prashant K. / Design and development of thiolated graphene oxide nanosheets for brain tumor targeting. In: International Journal of Polymeric Materials and Polymeric Biomaterials. 2019.
@article{cc96997c0cbf40808ac9bf416ca1a9dd,
title = "Design and development of thiolated graphene oxide nanosheets for brain tumor targeting",
abstract = "The present investigation emphasizes on synthesis and characterization of thiol functionalized reduced graphene oxide (TrGO) as a novel platform for loading of anticancer drug methotrexate (TrGO-MTX), through amide bonding. Thiolation of graphene oxide (GO) was achieved by transesterification process. The introduction of sulfur containing chemical groups and the partial reduction of GO to TrGO were proven by analytical techniques. Thiol content was found to be 6.98 mM by Ellman’s method in a quantitative manner. Furthermore, antineoplastic action of TrGO-MTX against human glioblastoma astrocytom U-373 MG cell line was studied, wherein TrGO-MTX demonstrated significant inhibition rate as compared with pure MTX.",
author = "Nikam, {Ajinkya N.} and More, {Mahesh P.} and Pandey, {Abhijeet P.} and Patil, {Pravin O.} and Patil, {Ashwini G.} and Deshmukh, {Prashant K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/00914037.2019.1596911",
language = "English",
journal = "International Journal of Polymeric Materials and Polymeric Biomaterials",
issn = "0091-4037",
publisher = "Taylor and Francis Ltd.",

}

Design and development of thiolated graphene oxide nanosheets for brain tumor targeting. / Nikam, Ajinkya N.; More, Mahesh P.; Pandey, Abhijeet P.; Patil, Pravin O.; Patil, Ashwini G.; Deshmukh, Prashant K.

In: International Journal of Polymeric Materials and Polymeric Biomaterials, 01.01.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Design and development of thiolated graphene oxide nanosheets for brain tumor targeting

AU - Nikam, Ajinkya N.

AU - More, Mahesh P.

AU - Pandey, Abhijeet P.

AU - Patil, Pravin O.

AU - Patil, Ashwini G.

AU - Deshmukh, Prashant K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The present investigation emphasizes on synthesis and characterization of thiol functionalized reduced graphene oxide (TrGO) as a novel platform for loading of anticancer drug methotrexate (TrGO-MTX), through amide bonding. Thiolation of graphene oxide (GO) was achieved by transesterification process. The introduction of sulfur containing chemical groups and the partial reduction of GO to TrGO were proven by analytical techniques. Thiol content was found to be 6.98 mM by Ellman’s method in a quantitative manner. Furthermore, antineoplastic action of TrGO-MTX against human glioblastoma astrocytom U-373 MG cell line was studied, wherein TrGO-MTX demonstrated significant inhibition rate as compared with pure MTX.

AB - The present investigation emphasizes on synthesis and characterization of thiol functionalized reduced graphene oxide (TrGO) as a novel platform for loading of anticancer drug methotrexate (TrGO-MTX), through amide bonding. Thiolation of graphene oxide (GO) was achieved by transesterification process. The introduction of sulfur containing chemical groups and the partial reduction of GO to TrGO were proven by analytical techniques. Thiol content was found to be 6.98 mM by Ellman’s method in a quantitative manner. Furthermore, antineoplastic action of TrGO-MTX against human glioblastoma astrocytom U-373 MG cell line was studied, wherein TrGO-MTX demonstrated significant inhibition rate as compared with pure MTX.

UR - http://www.scopus.com/inward/record.url?scp=85064627611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064627611&partnerID=8YFLogxK

U2 - 10.1080/00914037.2019.1596911

DO - 10.1080/00914037.2019.1596911

M3 - Article

AN - SCOPUS:85064627611

JO - International Journal of Polymeric Materials and Polymeric Biomaterials

JF - International Journal of Polymeric Materials and Polymeric Biomaterials

SN - 0091-4037

ER -